Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression
Authors:
Open Access
- 24 November 2017
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 39 (2) , 619-626
Abstract
The microRNA miR-19a is closely related to tumor formation and development and is a key oncogene. Previous studies have demonstrated that miR-19a is upregulated in multiple cancer types, including colorectal cancer (CRC). However, most of these experiments were performed in vitro, and consequently, the mechanisms underlying the effects of miR-19a on CRC are still unclear. Therefore, in the present study, we investigated the role of miR-19a in the development of solid CRC tumors. We generated KRAS 3'UTR-Mut by deleting the predicted binding site for miR-19a in KRAS, and observed that the expression of a reporter gene containing the KRAS 3'UTR in HCT116 cells was suppressed by miR-19a, while that of a reporter gene with mutant KRAS 3'UTR was unaffected by miR-19a. We observed that high miR-19a levels reduced KRAS expression. In the tube formation assay, overexpression of miR-19a exhibited anti-angiogenesis effects, which were rescued by KRAS expression. We established a nude mouse xenograft model to investigate the specific role of miR-19a in solid tumors. The results revealed that the sizes of xenograft tumors and density of blood vessels developed from HCT116 cells expressing miR-19a were smaller/lower compared with those of the control. KRAS and VEGFA levels were also reduced. In conclusion, our results revealed that miR-19a overexpression supressed KRAS expression and angiogenesis in CRC, indicating possibilities of using miR-19a in future therapeutic applications.Keywords
This publication has 23 references indexed in Scilit:
- Oncogenic Kras drives invasion and maintains metastases in colorectal cancerGenes & Development, 2017
- MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-MybCell, 2016
- Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signalingProceedings of the National Academy of Sciences, 2015
- KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancerMolecular Oncology, 2015
- MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasionMolecular and Cellular Biochemistry, 2013
- MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progressionBritish Journal of Cancer, 2009
- Tube Formation: an In Vitro Matrigel Angiogenesis Assay2008
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- A microRNA polycistron as a potential human oncogeneNature, 2005
- The association of k-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinomaCancer, 2001